Benchmark Holdings PLC
BMK.OL
| Exchange: | OL |
| Currency | Norwegian Krone |
| Fiscal Year End: | September |
| Sector: | Consumer Defensive |
| Industry: | Packaged Foods |
| Gic Sector: | Health Care |
| Gic Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| Gic Industry: | Pharmaceuticals |
| Gic Sub Industry: | Pharmaceuticals |
| Description: | Benchmark Holdings plc, together with its subsidiaries, engages in the provision of technical services, products, and specialist knowledge that supports the development of food and farming industries. It operates through Genetics, Advanced Nutrition, and Health segments. The Genetics segment offers sea bass and bream, salmon, and shrimp breeding technologies and production facilities to the harnesses industry to provide various genetic merit ova. The Advanced Nutrition segment manufactures and provides nutrition and health products to the aquaculture industry. The Health segment provides health products, including Ectosan Vet and Clean Treat medicinal sea lice solutions to the aquaculture market. The company operates in the United Kingdom, Norway, Vietnam, Iceland, the Faroe Islands, China, Ecuador, India, Canada, Greece, Chile, Turkey, rest of the Europe, and internationally. Benchmark Holdings plc was incorporated in 2000 and is headquartered in Sheffield, the United Kingdom. |
| Address: | 4 Park Square, Sheffield, United Kingdom, S35 2PH |
| Website: | https://www.benchmarkplc.com |
| Full Time Employees: | 823 |
| Updated On: | 2024-11-03 |
Highlights
| Market Capitalization: | 4068823040 |
| Market Capitalization Mln: | 4068.82 |
| EBITDA: | 16487000 |
| Book Value: | 0.33 |
| Earnings Share: | -0.56 |
| Most Recent Quarter: | 2024-06-30 |
| Profit Margin: | -0.22 |
| Operating Margin TTM: | -0.13 |
| Return On Assets TTM: | -0.01 |
| Return On Equity TTM: | -0.10 |
| Revenue TTM: | 147506000 |
| Revenue Per Share TTM: | 0.19 |
| Quarterly Revenue Growth YOY: | -0.10 |
| Gross Profit TTM: | 83128000 |
| Diluted Eps TTM: | -0.56 |
Valuation
| Forward PE: | 41.15 |
| Price Sales TTM: | 27.58 |
| Price Book MRQ: | 1.15 |
| Enterprise Value: | 4995443682 |
| Enterprise Value Revenue: | 2.38 |
| Enterprise Value Ebitda: | 15.49 |
Shares
| Shares Outstanding: | 739785984 |
| Shares Float: | 183908971 |
| Percent Insiders: | 5.79 |
| Percent Institutions: | 91.15 |
Technicals
| Beta: | 0.69 |
| 52 Week High: | 6.8 |
| 52 Week Low: | 4.52 |
| 50 Day MA: | 5.45 |
| 200 Day MA: | 6.29 |
Earnings
| Report Date: | 2025-05-20 |
| Date: | 2025-03-31 |
| Before After Market: | After Market |
| Report Date: | 2025-02-13 |
| Date: | 2024-12-31 |
| Before After Market: | Before Market |
| Report Date: | 2024-11-27 |
| Date: | 2024-09-30 |
| Before After Market: | Before Market |
| Report Date: | 2024-08-22 |
| Date: | 2024-06-30 |
| Before After Market: | Before Market |
| Eps Actual: | -0.18 |
| Report Date: | 2024-05-22 |
| Date: | 2024-03-31 |
| Before After Market: | Before Market |
| Eps Actual: | -0.02 |
| Report Date: | 2024-02-15 |
| Date: | 2023-12-31 |
| Before After Market: | Before Market |
| Eps Actual: | -0.13 |
| Report Date: | 2023-11-29 |
| Date: | 2023-09-30 |
| Before After Market: | Before Market |
| Eps Actual: | -0.24 |
| Report Date: | 2023-08-24 |
| Date: | 2023-06-30 |
| Eps Actual: | -0.09 |
| Report Date: | 2023-05-23 |
| Date: | 2023-03-31 |
| Eps Actual: | -0.04 |
| Report Date: | 2023-02-28 |
| Date: | 2022-12-31 |
| Eps Actual: | -0.02 |
| Date: | 2024-09-30 |
| Eps Actual: | -0.34 |
| Date: | 2023-09-30 |
| Eps Actual: | -0.41 |